Tetrahydrocyclopenta(b) indole compounds as androgen receptor modulators

Details for Australian Patent Application No. 2007324046 (hide)

Owner Eli Lilly and Company

Inventors Jadhav, Prabhakar Kondaji; Green, Jonathan Edward; Matthews, Donald Paul; Gavardinas, Konstantinos

Agent Spruson & Ferguson

Pub. Number AU-B-2007324046

PCT Pub. Number WO2008/063867

Priority 60/866,484 20.11.06 US

Filing date 6 November 2007

Wipo publication date 29 May 2008

Acceptance publication date 5 April 2012

International Classifications

C07D 209/58 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/063867 Priority application(s): WO2008/063867

5 April 2012 Application Accepted

  Published as AU-B-2007324046

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324065-Oxazolidinium compounds and use as hydrate inhibitors

2007324044-Biphosphonate inhalant formulations and methods for using the same